Ireland - English - HPRA (Health Products Regulatory Authority)

sandoz gmbh - rifampicin - capsule - 150mg milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

sandoz gmbh - rifampicin - capsule - 300mg milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

sandoz gmbh - rifampicin isoniazid - coated tablets - 300/150mg milligram

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - baclofen -

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - megestrol acetate -

New Zealand - English - Medsafe (Medicines Safety Authority)

apotex nz ltd - megestrol acetate 160mg - tablet - 160 mg - active: megestrol acetate 160mg excipient: colloidal silicon dioxide croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose - apo-megestrol is indicated for the palliative treatment of advanced carcinoma of the breast or endometrium (i.e. recurrent, inoperable or metastatic diseases). it should not be used in lieu of currently accepted procedures such as surgery, radiation or chemotherapy. apo-megestrol is indicated for the treatment of anorexia, cachexia, or a significant weight loss in patients with a diagnosis of acquired immunodeficiency syndrome (aids).

New Zealand - English - Medsafe (Medicines Safety Authority)

apotex nz ltd - megestrol acetate 40mg - tablet - 40 mg - active: megestrol acetate 40mg excipient: brilliant blue fcf colloidal silicon dioxide croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose - apo-megestrol is indicated for the palliative treatment of advanced carcinoma of the breast or endometrium (i.e. recurrent, inoperable or metastatic diseases). it should not be used in lieu of currently accepted procedures such as surgery, radiation or chemotherapy. apo-megestrol is indicated for the treatment of anorexia, cachexia, or a significant weight loss in patients with a diagnosis of acquired immunodeficiency syndrome (aids).

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - hydralazine hydrochloride 20 mg/ml - powder for injection - 20 mg/ml - active: hydralazine hydrochloride 20 mg/ml - for the treatment of chronic congestive heart failure as adjunct to long-acting nitrates, digitalis and other positive-inotropic agents and/or diuretics.

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - hydralazine hydrochloride 25mg - tablet - 25 mg - active: hydralazine hydrochloride 25mg excipient: colloidal silicon dioxide dispersed yellow 15093, coat copovidone hypromellose macrogol 8000   magnesium stearate microcrystalline cellulose   opacode brown s-1-26593 povidone   purified talc   sucrose   titanium dioxide wheat starch - for the treatment of moderate to severe hypertension as an adjunct to other anti-hypertensive agents e.g. beta-blockers and diuretics.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - megestrol acetate 160mg;   - tablet - 160 mg - active: megestrol acetate 160mg   excipient: colloidal silicon dioxide lactose monohydrate magnesium stearate microcrystalline cellulose povidone sodium starch glycolate